Skip to main content

Table 1 Differences Between Groups in Monthly Medication Costs

From: Medication costs during an 18 month clinical trial of obesity treatment among patients encountered in primary care

 

Standard Maintenance

Intensified Maintenance

Between-group difference

p value

Month 0

266.83(79.11)

273.12(76.05)

6.29(115.47)

n/a

Month 6

228.56(70.48)

241.84(66.7)

13.27(101.33)

0.45

Month 18

222.19(69.99)

275.29(78.35)

53.11(109.62)

0.31

Change: Month 6- Month 18

    

Total cost

−6.38(104.74)

33.46(104.68)

39.83(147.52)

0.61

Weight-related medicationsa, b

−3.58(65.68)

−63.36(56.01)

59.78(86.5)

0.24

Non-weight-related medicationsa, b

−7.49(54.22)

54.32(67.7)

61.81(86.87)

0.76

Change: Month 0 – Month 18

    

Total cost

−44.64(111.98)

2.18(113.8)

46.82(160.76)

n/a

Weight-related medicationsa, b

−0.72(65.05)

−11.51(47.14)

10.79(81.08)

n/a

Non-weight-related medicationsa, b

−31.06(61.04)

−4.37(80.72)

26.69(102.87)

n/a

  1. a Data are presented as mean (se) in 2013 U.S. dollar amounts
  2. a, b Medications for weight-related conditions are those for diabetes, hypertension, and cholesterol
  3. † P values for Month 0 and change from Month 0 to Month 18 are not applicable since these were not a priori planned comparisons (i.e., randomization occurred at month 6)